Clinical Trial

Aerobic Versus Leisure Group for Adolescents With Depression

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated June 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim is to evaluate aerobic group exercise versus leisure group activities in adolescents with mild to moderate depression. Primary outcome is Children's Depression Rating Scale - Revised (CDRS-R). Secondary outcomes are Clinical Global Impressions - Severity and Improvement scales (CGI), self-reported Quick Inventory of Depression Symptomatology (QIDS- A17-SR), the self-reported Outcome Rating Scale (ORS), clinician rated Children Global Assessment Scale (C-GAS), aerobic capacity (VO2max), muscular strength, body, Body Mass Index (BMI), presence or activity of selected biological markers of neuroprotection and neuroinflammation in blood samples and a cost evaluation rated by parents with Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (Tic-P) and the Child Health Utility (CHU9D) to facilitate estimation of Quality Adjusted Life Years. Further objectives are qualitative interviews to explore adolescents' experiences of the intervention as well as how their health and lifestyle are influenced and a validation of QIDS- A17-C and QIDS- A17-SR versus CDRS-R will be performed.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-09-30; most recent amendment 2025-03-21.
Status change: Not Yet Recruiting → Recruiting 2022-03-29
Trial Details
NCT Number NCT05076214
Lead Sponsor Lund University Hospital
Collaborators: Region Halland, Halmstad University, Karolinska University Hospital, The Rydberg Laboratory for Applied Sciences, Halmstad, Sweden, Region Skane, PRIMA Barn- och Vuxenpsykiatri AB
Conditions Depressive Disorder, Major
Enrollment 122 participants
Start Date 2022-02-28
Primary Completion 2025-06-10 (estimated)
Study Completion 2026-03-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-26